✦ LIBER ✦

Healthcare utilization and cost of pneumococcal disease in the United States

✍ Scribed by Susan S. Huang; Kristen M. Johnson; G. Thomas Ray; Peter Wroe; Tracy A. Lieu; Matthew R. Moore; Elizabeth R. Zell; Jeffrey A. Linder; Carlos G. Grijalva; Joshua P. Metlay; Jonathan A. Finkelstein

Book ID: 116963605
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 751 KB
Volume: 29
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2011.02.088

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-Effectiveness of Pneumococcal Vacci

Cost-Effectiveness of Pneumococcal Vaccines for Adults in the United States

✍ Chen, Jieling; O’Brien, Megan A.; Yang, H. Keri; Grabenstein, John D.; Dasbach, 📂 Article 📅 2014 🏛 Springer Healthcare Communications 🌐 English ⚖ 913 KB

The Healthcare Costs of Sarcopenia in th

The Healthcare Costs of Sarcopenia in the United States

✍ Ian Janssen; Donald S. Shepard; Peter T. Katzmarzyk; Ronenn Roubenoff 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

Cost-Effectiveness Of Pneumococcal Vacci

Cost-Effectiveness Of Pneumococcal Vaccines For Adults In The United States

✍ Yang, H.K.; Chen, J.; O'Brien, M.; Grabenstein, J.; Dasbach, E. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

Finger replantation in the United States

Finger replantation in the United States: Rates and resource use from the 1996 Healthcare Cost and Utilization Project

✍ Kevin C. Chung; Christine P. Kowalski; Madonna R. Walters 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 36 KB

Healthcare resource utilization among ha

Healthcare resource utilization among haemophilia A patients in the United States

✍ L. A. VALENTINO; S. W. PIPE; M. D. TARANTINO; X. YE; Y. XIONG; M. P. LUO 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 417 KB

Incremental healthcare utilization and e

Incremental healthcare utilization and expenditures for allergic rhinitis in the United States

✍ Neil Bhattacharyya 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

Objective: Determine incremental increases in healthcare expenditures and utilization associated with allergic rhinitis (AR). Methods: Patients reporting a diagnosis of AR were extracted from the 2007 Medical Expenditure Panel Survey medical conditions file and linked to the consolidated expenditur